about
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesAdvanced measurement techniques of regional myocardial function to assess the effects of cardiac regenerative therapy in different models of ischaemic cardiomyopathyConcise review: heart regeneration and the role of cardiac stem cellsTraditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice.MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cellsWnt/β-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes.MicroRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells.Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease.Assessment of coronary microvascular resistance in the chronic infarcted pig heart.Inhibition of miR-25 improves cardiac contractility in the failing heart.Foetal and adult cardiomyocyte progenitor cells have different developmental potentialHuman relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease.Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology.Cardiac allograft vasculopathy: a donor or recipient induced pathology?Multimodality infarct identification for optimal image-guided intramyocardial cell injections.Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial InfarctionIsolation and expansion of resident cardiac progenitor cells.Long non-coding RNAs in heart failure: an obvious lnc.Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury.Crucial Role of miR-433 in Regulating Cardiac FibrosisSequential use of human-derived medium supplements favours cardiovascular tissue engineering.Expanding mouse ventricular cardiomyocytes through GSK-3 inhibition.Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart.Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium.Environmental regulation of valvulogenesis: implications for tissue engineering.Human cardiomyocyte progenitor cells: a short history of nearly everything.Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection.Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.Concise review: Engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technologyCirculating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome.Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors.Microvesicles and exosomes for intracardiac communication.Novel therapeutic strategies for cardioprotection.Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.Cardiac Stem Cell Treatment in Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical Studies.Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models.Stem cell-based therapy: Improving myocardial cell delivery.Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype.Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs.
P50
Q24289195-ADEEB09C-D911-4994-9E86-89C43E72995EQ27021792-5F723259-6C42-4A2F-9212-8E488F1CCF8BQ27021931-487DBD97-D66B-44C6-A5FE-B717700E3ECAQ27309112-7AC4DD1C-353A-49A9-A810-8590BF03C590Q28116756-FC8AA843-5409-46FC-BD2E-E187A4C17201Q30547782-E07F6179-AA48-4250-A527-E484B2C236C6Q32884452-1A31496B-8F7F-4619-8732-2317D24D2B41Q33348628-BEF85D35-CDA1-46B5-93A6-78D602CE78D4Q33985618-9D00E498-5EFB-4BB5-A2E7-8340898F8CC5Q34040266-57E1382E-BC89-42AB-93B6-B3A93E225A6AQ34103190-F7A79FEB-69E9-4022-AE04-861379CA8235Q34178870-CE7EA83A-5595-412B-B527-A0B5B96C359CQ34938752-532623C0-7366-442F-A5A3-25015BBB31EBQ35244151-5A879A39-641C-4208-8267-E45FBFE50566Q35337705-187E421D-4DD3-47EB-9774-E65B6ACF1307Q36214819-C72FBC33-07A1-44E8-9F65-F5FF2B2B422EQ36691627-70C57A68-B3BD-4FF0-99C7-76F48531CF62Q36924947-5A314FDE-764A-432A-AB24-B6FA29D99F7AQ37016190-CE056100-C78E-4ECD-A529-C14FD926A6E0Q37188204-6F7F5D49-86F7-45AC-B671-320DE134C666Q37291267-8E972B1A-D851-4BFD-8CEE-058E29495E1DQ37294609-0C3C01D6-3125-4A22-85CB-EE84BE9D1744Q37602428-78CD3993-E4F9-48E4-99F0-C905EFD2729DQ37603820-267DCB51-5F38-4244-9EDA-5949A4778AA2Q37767614-FABF9BF9-B884-4586-A184-C37BBE1FB55EQ37773530-149E15E6-A07C-42C1-90A9-DD0D71FDEA34Q37977129-1CBC6D51-0E48-41D1-918C-0B4574518C17Q37998218-9EEEBF21-8DD8-408A-A9B4-D7083AA05FCDQ38075417-9A338A0F-11BE-407B-BE4D-CAFAEFEC9688Q38120722-4DF770FE-B664-4E8E-A210-816B1099A81FQ38125100-B4C27365-2BA3-4550-8CED-C93B60FA9C90Q38175951-E5C852D0-F04E-4E99-944D-9B77B45478B8Q38184460-22ED51BE-6BE2-4A73-848C-CAFA9DFAED63Q38212450-A028EAFE-6B02-43B2-AC64-AE4689D162DBQ38217461-8DBA7136-AE1D-406E-A10D-2080987E4230Q38738174-C6F447A3-65A9-4374-961D-FB569E84E304Q38788603-E651B2DA-4DE0-4A51-90D1-ED09661B8474Q38822336-83C7DE2F-AAB3-460E-9C81-E8C2469E03D6Q39977732-2285A830-C483-4C9E-88BB-041492AC4F3FQ41703806-0BA7CE2E-7A9F-4ADD-B5B6-4CEFAB2603EF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joost Sluijter
@ast
Joost Sluijter
@en
Joost Sluijter
@es
Joost Sluijter
@nl
type
label
Joost Sluijter
@ast
Joost Sluijter
@en
Joost Sluijter
@es
Joost Sluijter
@nl
prefLabel
Joost Sluijter
@ast
Joost Sluijter
@en
Joost Sluijter
@es
Joost Sluijter
@nl
P106
P1153
6602905237
P31
P496
0000-0003-2088-9102